AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Daily Turnover | The turnover of RELX on 12/1 was $142.61 Million, Ranking 711
ByAinvest
Monday, Dec 1, 2025 5:00 pm ET1min read
The turnover of RELX on 12/1/2025 was $142.61 million, ranking 711 in today's market, the Volume is 3.58 million.
RELX(RELX) shares closed at $39.72, down 1.22% on 12/1/2025, down 1.56% in the last 5 trading days, down 1.22% this month, down 12.55% year-to-date and down 16.08% in the last 52 weeks.
*If the company has been listed for less than 52 weeks, the 52-week gain is the gain since the listing.
(The same applies for less than 1 month, or less than 5 trading days)
【History Turnover】
| Date | Turnover | Volume | Price | Performance |
|---|---|---|---|---|
| 12/1/2025 | $142.61 million | 3.58 million | $39.72 | -1.22% |
| 11/28/2025 | $42.13 million | 1.05 million | $40.21 | 0.07% |
| 11/26/2025 | $58.31 million | 1.45 million | $40.18 | -0.47% |
| 11/25/2025 | $132.80 million | 3.30 million | $40.37 | 0.05% |
| 11/24/2025 | $114.16 million | 2.84 million | $40.35 | -0.62% |
【Company Profile】
RELX PLC is a public limited company, incorporated in England under the UK Companies Act 2006. The company is a global provider of information-based analytics and decision tools for professional and business customers. The companyserves customers in more than 180 countries and has offices in about 40 countries. The company operate in four major market segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. Risk provides customers with information-based analytics and decision tools that combine public and industry-specific content with advanced technology and algorithms to assist them in evaluating and predicting risk and enhancing operational efficiency. Scientific, Technical & Medical helps researchers and healthcare professionals advance science and improve health outcomes by combining quality information and data sets with analytical tools to facilitate insights and critical decision-making. Legal provides legal, regulatory and business information and analytics that help customers increase their productivity, improve decision-making and achieve better outcomes. Exhibitions combines industry expertise with data and digital tools to help customers connect face-to-face and digitally, learn about markets, source products and complete transactions.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet